ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Sees Significant Decline in Short Interest

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 7,980,000 shares, a drop of 13.5% from the September 15th total of 9,230,000 shares. Based on an average daily trading volume, of 1,730,000 […]

Leave a Reply

Your email address will not be published.

Previous post JPMorgan Chase & Co. Increases General Mills (NYSE:GIS) Price Target to $67.00
Next post USA Q3 2024: Market down -2.1%, Chevrolet Trax in Top 10